Composition for preventing or treating pulmonary fibrosis disease comprising M-CSF inhibitor and G-CSF inhibitor as an active ingredient

Item Number: 642
Industry: Therapeutic
Category: Fibrosis
Development Stage: Early Stage
Organisation Type: University
Country: South Korea
Patent: Korea, PCT
Business Opportunity: Out-Licensing, Technology Transfer, Collaboration R&D

DESCRIPTION

The present invention relates to composition for preventing or treating pulmonary fibrosis disease comprising M-CSF inhibitor and G-CSF inhibitor as an active ingredient. More particularly, it includes composition for preventing or treating pulmonary fibrosis disease by decreasing factors related to myofibroblast differentiation, epithelial to mesenchymal transition and extracellular matrix remodelling through inhibition of M-SCF and G-CSF.

7612462_1.jpg


Features & Contact

Sign in and you'll be able to send enquiries about this item, view full details and save it


SIGN IN